{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:22:31Z","timestamp":1780374151506,"version":"3.54.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Perinatology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.semperi.2022.151585","type":"journal-article","created":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T23:36:36Z","timestamp":1647128196000},"page":"151585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Novel approaches to the surveillance and management of fetuses at risk for anti-Ro\/SSA mediated atrioventricular block"],"prefix":"10.1016","volume":"46","author":[{"given":"Michelle","family":"Kaplinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina F.","family":"Cuneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semperi.2022.151585_bib0001","unstructured":"Buyon, J. P. Chapter 53 - Neonatal lupus: Clinical spectrum, biomarkers, pathogenesis, and approach to treatment. 13."},{"key":"10.1016\/j.semperi.2022.151585_bib0002","unstructured":"Julkunen, H. & Eronen, M. Long-term outcome of mothers of children with isolated heart block in Finland. 6."},{"key":"10.1016\/j.semperi.2022.151585_bib0003","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1067\/mpd.2003.233","article-title":"Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies","volume":"142","author":"Cimaz","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.semperi.2022.151585_bib0004","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIRCULATIONAHA.111.033894","article-title":"Maternal and Fetal Factors Associated With Mortality and Morbidity in a Multi\u2013Racial\/Ethnic Registry of Anti-SSA\/Ro\u2013Associated Cardiac Neonatal Lupus","volume":"124","author":"Izmirly Peter","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.semperi.2022.151585_bib0005","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ajog.2016.07.002","article-title":"Detection and successful treatment of emergent anti-SSA\u2013mediated fetal atrioventricular block","volume":"215","author":"Cuneo","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.semperi.2022.151585_bib0006","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/uog.20361","article-title":"Keeping upbeat to prevent the heartbreak of anti-Ro\/SSA pregnancy","volume":"54","author":"Cuneo","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.semperi.2022.151585_bib0007","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/uog.19277","article-title":"OC11.04: Fetal surveillance of anti-Ro\/anti-La affected pregnancies: is there a consensus? Results of an international survey","volume":"52","author":"Carvalho","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.semperi.2022.151585_bib0008","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/01.CIR.0000142046.58632.3A","article-title":"Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease","volume":"110","author":"Jaeggi Edgar","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.semperi.2022.151585_bib0009","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/CRD.0000000000000026","article-title":"Prevention and treatment in utero of autoimmune associated congenital heart block","volume":"22","author":"Saxena","year":"2014","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.semperi.2022.151585_bib0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-3083.2010.02440.x","article-title":"The Benefits of Transplacental Treatment of Isolated Congenital Complete Heart Block Associated with Maternal Anti-Ro \/SSA Antibodies: A Review","volume":"72","author":"Hutter","year":"2010","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.semperi.2022.151585_bib0011","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1161\/CIRCULATIONAHA.111.041970","article-title":"Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients","volume":"124","author":"Eliasson","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.semperi.2022.151585_bib0012","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/art.20126","article-title":"Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA\/Ro 52-kd antibodies","volume":"50","author":"Sonesson","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semperi.2022.151585_bib0013","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/uog.20245","article-title":"Assessment of atrioventricular conduction by echocardiography and magnetocardiography in normal and anti-Ro\/SSA-antibody-positive pregnancies","volume":"54","author":"Cuneo","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.semperi.2022.151585_bib0014","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrrheum.2015.29","article-title":"The clinical spectrum of autoimmune congenital heart block","volume":"11","author":"Brito-Zer\u00f3n","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semperi.2022.151585_bib0016","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0735-1097(01)01697-7","article-title":"Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block: A single institution's experience of 30 years","volume":"39","author":"Jaeggi","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semperi.2022.151585_bib0017","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/14767050802488220","article-title":"An expanded phenotype of maternal SSA\/SSB antibody-associated fetal cardiac disease","volume":"22","author":"Cuneo","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.semperi.2022.151585_bib0018","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0735-1097(00)01048-2","article-title":"Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela","volume":"37","author":"Moak","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semperi.2022.151585_bib0019","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-3083.2010.02437.x","article-title":"Spectrum of Cardiac Involvement in Neonatal Lupus: Spectrum of Cardiac Involvement in NLE","volume":"72","author":"Hornberger","year":"2010","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.semperi.2022.151585_bib0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/annrheumdis-2019-215900","article-title":"Factors associated with long-term cardiac dysfunction in neonatal lupus","volume":"79","author":"Saxena","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semperi.2022.151585_bib0021","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jacc.2007.06.060","article-title":"Electrophysiological Characteristics of Fetal Atrioventricular Block","volume":"51","author":"Zhao","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semperi.2022.151585_bib0022","article-title":"Outcome in 212 anti-Ro\/SSA-positive pregnancies and population-based incidence of congenital heart block","volume":"8","author":"Skog","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.semperi.2022.151585_bib0023","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0735-1097(98)00161-2","article-title":"Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a National Neonatal Lupus Registry","volume":"31","author":"Buyon","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semperi.2022.151585_bib0024","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1002\/art.24768","article-title":"Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal\/fetal risk factors","volume":"60","author":"Llanos","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semperi.2022.151585_bib0025","unstructured":"Spence D, Hornberger L, Hamilton R. & Silverman ED. Increased Risk of Complete Congenital Heart Block in Infants Born to Women with Hypothyroidism and Anti-Ro and\/or Anti-La Antibodies. J Rheumatol 4."},{"key":"10.1016\/j.semperi.2022.151585_bib0026","unstructured":"Gordon P. et\u00a0al. Anti-52 kDa Ro, Anti-60 kDa Ro, and Anti-La Antibody Profiles in Neonatal Lupus. J Rheumatol. 8."},{"key":"10.1016\/j.semperi.2022.151585_bib0027","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1016\/j.jacc.2010.02.042","article-title":"The importance of the level of maternal anti-Ro\/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus: a prospective study of 186 antibody-exposed fetuses and infants","volume":"55","author":"Jaeggi","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semperi.2022.151585_bib0028","doi-asserted-by":"crossref","first-page":"S643","DOI":"10.1016\/j.ajog.2020.12.1062","article-title":"1037 Reducing the burden of fetal surveillance using the negative predictive value of anti-Ro antibody titer","volume":"224","author":"Kaizer","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.semperi.2022.151585_bib0029","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/CIRCULATIONAHA.107.707661","article-title":"Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study","volume":"117","author":"Friedman","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.semperi.2022.151585_bib0030","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.jacc.2018.07.076","article-title":"Home monitoring for fetal heart rhythm during anti-Ro pregnancies","volume":"72","author":"Cuneo","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semperi.2022.151585_bib0015","article-title":"Classic and atypical Wenckebach periodicity in a late gestation fetus with maternal anti-Ro\/SSA antibodies","author":"Gropler","year":"2021","journal-title":"Hear Case Rep"},{"key":"10.1016\/j.semperi.2022.151585_bib0031","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0735-1097(02)02004-1","article-title":"Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block","volume":"40","author":"Nield","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semperi.2022.151585_bib0032","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/hc0702.104182","article-title":"Maternal anti-Ro and anti-La antibody\u2013associated endocardial fibroelastosis","volume":"105","author":"Nield","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.semperi.2022.151585_bib0033","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.jacc.2010.12.014","article-title":"Prolongation of the atrioventricular conduction in fetuses exposed to maternal anti-Ro\/SSA and anti-La\/SSB antibodies did not predict progressive heart block: a prospective observational study on the effects of maternal antibodies on 165 fetuses","volume":"57","author":"Jaeggi","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semperi.2022.151585_bib0034","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ahj.2003.09.016","article-title":"Postnatal outcome of fetal bradycardia without significant cardiac abnormalities","volume":"147","author":"Lin","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.semperi.2022.151585_bib0035","article-title":"Fetal arrhythmias: the Saint-Justine hospital experience","volume":"14","author":"Fouron","year":"2004","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.semperi.2022.151585_bib0036","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/jp.2016.220","article-title":"Heart sounds at home: feasibility of an ambulatory fetal heart rhythm surveillance program for anti-SSA-positive pregnancies","volume":"37","author":"Cuneo","year":"2017","journal-title":"J Perinatol"},{"key":"10.1016\/j.semperi.2022.151585_bib0037","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12016-009-8190-6","article-title":"Pregnancy outcomes in patients with autoimmune diseases and anti-Ro\/SSA antibodies","volume":"40","author":"Brucato","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.semperi.2022.151585_bib0038","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","article-title":"Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA\/Ro-antibody\u2013associated cardiac manifestations of neonatal lupus","volume":"126","author":"Izmirly Peter","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.semperi.2022.151585_bib0039","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2009.119263","article-title":"Evaluation of the risk of anti-SSA\/Ro-SSB\/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine","volume":"69","author":"Izmirly","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semperi.2022.151585_bib0040","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1002\/art.22157","article-title":"Antimalarial agents: Closing the gate on toll-like receptors?","volume":"54","author":"Lafyatis","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semperi.2022.151585_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.12.1219","article-title":"Hydroxychloroquine early in pregnancy and risk of birth defects","volume":"224","author":"Huybrechts","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.semperi.2022.151585_bib0043","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1546-0096-7-9","article-title":"Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases","volume":"7","author":"Sperber","year":"2009","journal-title":"Pediatr Rheumatol"},{"key":"10.1016\/j.semperi.2022.151585_bib0041","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/art.27308","article-title":"Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial","volume":"62","author":"Friedman","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semperi.2022.151585_bib0044","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/ard.62.10.1010","article-title":"Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block","volume":"62","author":"Costedoat-Chalumeau","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semperi.2022.151585_bib0045","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.amjcard.2008.12.027","article-title":"Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study","volume":"103","author":"Friedman","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.semperi.2022.151585_bib0046","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/uog.1713","article-title":"Treatment of fetal heart block with maternal steroid therapy: case report and review of the literature","volume":"24","author":"Breur","year":"2004","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.semperi.2022.151585_bib0047","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/1529-0131(199911)42:11<2335::AID-ANR12>3.0.CO;2-3","article-title":"Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus","volume":"42","author":"Saleeb","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semperi.2022.151585_bib0048","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/uog.20214","article-title":"Benefits of fetal echocardiographic surveillance in pregnancies at risk of congenital heart block: single-center study of 212 anti-Ro52-positive pregnancies","volume":"54","author":"Sonesson","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.semperi.2022.151585_bib0049","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.amjcard.2015.03.051","article-title":"Isolated Complete Heart Block in the Fetus","volume":"116","author":"Ho","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.semperi.2022.151585_bib0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000513202","article-title":"Effects of Transplacental Dexamethasone Therapy on Fetal Immune-Mediated Complete Heart Block","volume":"48","author":"Saito","year":"2021","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.semperi.2022.151585_bib0051","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jacc.2010.09.044","article-title":"Use of Intravenous Gamma Globulin and Corticosteroids in the Treatment of Maternal Autoantibody-Mediated Cardiomyopathy","volume":"57","author":"Trucco","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semperi.2022.151585_bib0052","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/pd.4454","article-title":"Outcomes of fetal echocardiographic surveillance in anti-SSA exposed fetuses at a large fetal cardiology center","volume":"34","author":"Krishnan","year":"2014","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.semperi.2022.151585_bib0053","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.amjcard.2007.03.081","article-title":"Atrial and Ventricular Rate Response and Patterns of Heart Rate Acceleration during Maternal\u2013Fetal Terbutaline Treatment of Fetal Complete Heart Block","volume":"100","author":"Cuneo","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.semperi.2022.151585_bib54","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.0000142046.58632.3A","article-title":"Transplacental Fetal Treatment Improves the Outcome of Prenatally Diagnosed Complete Atrioventricular Block Without Structural Heart Disease","author":"Jaeggi","year":"2004","journal-title":"Circulation"}],"container-title":["Seminars in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000522000143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000522000143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T02:22:55Z","timestamp":1673058175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146000522000143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0146000522000143"],"URL":"https:\/\/doi.org\/10.1016\/j.semperi.2022.151585","relation":{},"ISSN":["0146-0005"],"issn-type":[{"value":"0146-0005","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel approaches to the surveillance and management of fetuses at risk for anti-Ro\/SSA mediated atrioventricular block","name":"articletitle","label":"Article Title"},{"value":"Seminars in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semperi.2022.151585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"151585"}}